New breast imaging algorithm brings breast cancer diagnosis and treatment to underserved area of Uganda

Key points
- Radiologists are a step closer to implementing a program in an underserved region of Uganda for diagnosing and treating women with palpable breast masses.
- The program combines a unique diagnostic algorithm along with targeted community outreach, said medical student Chris Duncan working with the organization Imaging the World.
- "We just returned from a trip to Kamuli, Uganda where we laid the groundwork for implementation of the diagnostic algorithm," said Mr.
- The diagnostic algorithm is designed to be simpler and more effective than the current course of breast cancer diagnosis and treatment for women in Uganda, a region where most breast cancer patients are diagnosed with late stage breast cancer, said Mr.
Radiologists are a step closer to implementing a program in an underserved region of Uganda for diagnosing and treating women with palpable breast masses.
The program combines a unique diagnostic algorithm along with targeted community outreach, said medical student Chris Duncan working with the organization Imaging the World. Imaging the World, a non-profit organization dedicated to bringing diagnostic imaging to underserved areas around the world, has multiple obstetrical imaging programs currently operating in Uganda and plans to expand both the obstetric imaging and breast imaging programs.
"We just returned from a trip to Kamuli, Uganda where we laid the groundwork for implementation of the diagnostic algorithm," said Mr. Duncan, a fourth year medical student at University of Vermont. "Our team met with local stakeholders, determined available treatments and identified potential barriers," he said. "The meetings helped ensure that we can create appropriate local resources prior to our program roll-out this summer," he said.
The diagnostic algorithm is designed to be simpler and more effective than the current course of breast cancer diagnosis and treatment for women in Uganda, a region where most breast cancer patients are diagnosed with late stage breast cancer, said Mr. Duncan.
The algorithm focuses on breast ultrasound as an initial diagnostic tool for evaluating palpable breast masses. The breast ultrasound exam is done by minimally trained personnel who follow a standardized scanning methodology. The ultrasound images are then compressed, uploaded to a server through a cellular network, and interpreted at another location by an imaging expert. (Research continues in the U.S. to evaluate the quality of the images obtained using the algorithm, with preliminary results suggesting that the images are more than adequate for evaluating breast masses, said Mr. Duncan)
After the images are interpreted, the results are sent back to the clinic where the ultrasound was performed. If the results indicate the need for a biopsy, the patient is referred to the district referral hospital. "We have trained local surgeons to perform both fine-needle and core biopsies using ultrasound guidance," said Mr. Duncan. If the biopsy is positive for cancer, the patient is referred to the major tertiary referral hospital in the capital city for treatment. "We are hiring a patient care navigator to assist women in the complicated and daunting process of receiving breast cancer care," said Mr. Duncan. "We are also working on obtaining funding for a lodging area where the women can stay during their treatment period in the capital city," he said.
The recent trip also emphasized the need for patient education. There are some in the community that believe that cancer is contagious, that surgery spreads cancer throughout the body or that cancer is due to curses, evil spirits and various other supernatural etiologies. "We hope that our education campaign will help to eradicate these myths, opening the path to early diagnosis and effective care for these women," said Mr. Duncan.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNeoadjuvant use of pertuzumab in HER2-positive breast cancer
Pertuzumab (trade name: Perjeta) is approved for two therapeutic indications. Its use in combination with trastuzumab and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable…
4 December 2015
NewsPotential new therapy for triple-negative breast cancer shows promise in lab studies
Recent laboratory findings provide novel insight into potential new therapeutic approaches for triple-negative breast cancer, a particularly difficult to treat and aggressive form of the disease. In a recent study…
28 October 2015
NewsUGR scientists patent an effective drug for treating breast, colon, and skin cancers
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on…
21 October 2015


